Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Alexandria Equities ( (ARE) ) has shared an announcement.
On May 13, 2026, Alexandria Real Estate Equities, Inc. held its 2026 Annual Meeting of Stockholders, with approximately 89% of eligible votes represented, at which stockholders elected eight directors to serve until the 2027 annual meeting, including Executive Chairman Joel S. Marcus and other incumbent board members. Shareholders also approved on a non-binding basis the compensation of the company’s named executive officers and ratified the appointment of Ernst & Young LLP as independent registered public accountants for the fiscal year ending December 31, 2026, reinforcing continuity in Alexandria’s governance, executive pay framework, and audit oversight.
The most recent analyst rating on (ARE) stock is a Hold with a $46.00 price target. To see the full list of analyst forecasts on Alexandria Equities stock, see the ARE Stock Forecast page.
Spark’s Take on ARE Stock
According to Spark, TipRanks’ AI Analyst, ARE is a Neutral.
The score is held back primarily by the sharp profitability breakdown and rising leverage, plus bearish technicals with the stock well below key moving averages. Support comes from resilient operating cash flow, reaffirmed 2026 FFO midpoint guidance alongside strong liquidity, and a very high dividend yield, though near-term occupancy/NOI pressure and reliance on dispositions temper the outlook.
To see Spark’s full report on ARE stock, click here.
More about Alexandria Equities
Alexandria Real Estate Equities, Inc. is a publicly traded real estate investment trust focused on owning, operating, and developing office and laboratory space, primarily for life sciences, technology, and related innovation-sector tenants. The company targets high-demand urban innovation clusters to serve research, biotech, and pharmaceutical clients seeking specialized facilities.
Average Trading Volume: 2,458,815
Technical Sentiment Signal: Sell
Current Market Cap: $8.1B
For an in-depth examination of ARE stock, go to TipRanks’ Overview page.

